In vivo and in vitro dopaminergic effects of three ergoline fragmentsKOONS, J. C; LONG, J. P; CANNON, J. G et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 2, pp 180-185, issn 0028-1298Article

Factors determining the remission of microprolactinomas after dopamine agonist withdrawalHUDA, M. S. B; ATHAUDA, N. B; TEH, M. M et al.Clinical endocrinology (Oxford. Print). 2010, Vol 72, Num 4, pp 507-511, issn 0300-0664, 5 p.Article

Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?FOWLER, C. J; THORELL, G; ANDERSSON, M et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 331, Num 1, pp 12-19, issn 0028-1298Article

Effect of apomorphine infusion on plasma homovanillic acid in normal subjectsDAVIDSON, M; KENDLER, K. S; MOHS, R. C et al.Journal of psychiatric research. 1986, Vol 20, Num 2, pp 131-135, issn 0022-3956Article

Hemiparkinsonism-Hemiatrophy SyndromeAYROMLOU, Hormoz; NAJMI, Safa; MOHAMMAD ALI ARAMI et al.Archives of Iranian medicine. 2011, Vol 14, Num 2, pp 152-154, 3 p.Article

Bromocriptine inhibition of hyperprolactinemia during surgeryJULLIEN, Y; ROCHETTE, A; DESCH, G et al.Acta obstetricia et gynecologica Scandinavica. 1985, Vol 64, Num 5, pp 403-405, issn 0001-6349Article

Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivoMARTIN, G. E; WILLIAMS, M; PETTIBONE, D. J et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 233, Num 2, pp 395-401, issn 0022-3565Article

Cardiac and Noncardiac Fibrotic Reactions Caused by Ergot-and Nonergot-Derived Dopamine AgonistsANDERSOHN, Frank; GARBE, Edeltraut.Movement disorders. 2009, Vol 24, Num 1, pp 129-133, issn 0885-3185, 5 p.Article

Fragmentation pathway of dopamine transporter ligands: N-substituted-2β-carbomethoxy-3β-phenylnortropane derivativesMAVEL, Sylvie; ABARBRI, Mohamed; FRANGIN, Yves et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 35, Num 1, pp 193-198, issn 0731-7085, 6 p.Article

Pergolide mesylate treatment of cocaine withdrawalMALCOLM, R; HUTTO, B. R; PHILLIPS, J. D et al.The Journal of clinical psychiatry. 1991, Vol 52, Num 1, pp 39-40, issn 0160-6689, 2 p.Article

Effects of hemivibrissotomy in the rat : time-dependent asymmetries in turning and biogenic amines induced by apomorphineSCHWARTING, R. K. W; STEINER, H; HUSTON, J. P et al.Pharmacology, biochemistry and behavior. 1990, Vol 35, Num 4, pp 989-994, issn 0091-3057Article

Agonistes dopaminergiques: utilisation, manifestations iatrogènes = Dopamine agonists: use and side effectsARNAUD-CASTIGLIONI, R; LOUVEL, E.Journal de psychiatrie biologique et thérapeutique. 1987, Num 26, pp 22-24, issn 0292-2509Article

Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiencyPORTA, F; MUSSA, A; CONCOLINO, D et al.Neurology. 2009, Vol 73, Num 8, pp 633-637, issn 0028-3878, 5 p.Article

Bromocriptine and psychosis: a literature reviewBOYD, A.Psychiatric quarterly. 1995, Vol 66, Num 1, pp 87-95, issn 0033-2720Article

Pre- and postsynaptic dopaminergic activities of U-86170FLAHTI, R. A; EVANS, D. L; FIGUR, L. M et al.Naunyn-Schmiedeberg's archives of pharmacology. 1991, Vol 344, Num 5, pp 509-513, issn 0028-1298Article

Management of catatonic stupor with L-dopaNEPPE, V. M.Clinical neuropharmacology. 1988, Vol 11, Num 1, pp 90-91, issn 0362-5664Article

Accumbens dopamine mediates the rewarding effect of orosensory stimulation by sucroseSMITH, Gerard P.Appetite (Print). 2004, Vol 43, Num 1, pp 11-13, issn 0195-6663, 3 p.Article

Accès soudains de sommeil sous ropinirole = Sudden sleep accesses under ropinirolLa Revue Prescrire. 2000, Vol 20, Num 202, issn 0247-7750, p. 35Article

Utilization of Gaussian functions for the rapid evaluation of molecular similarityGOOD, A. C; HODGKIN, E. E; RICHARDS, W. G et al.Journal of chemical information and computer sciences. 1992, Vol 32, Num 3, pp 188-191, issn 0095-2338Article

Stimulant effects of (+)-amphetamine are influenced by methodological variablesMAZURSKI, E. J; BENINGER, R. J.Progress in neuro-psychopharmacology & biological psychiatry. 1988, Vol 12, Num 2-3, pp 323-329, issn 0278-5846Conference Paper

Practical considerations in the use of apomorphine injectableBOWRON, Annette.Neurology. 2004, Vol 62, Num 6, pp S32-S36, issn 0028-3878, SUP4Article

New insight into structural and stereochemical requirements for selective, high affinity ligands at the dopamine D₂ receptorIMHOF, R; GODEL, T; BURKARD, W. P et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 75S-80S, issn 0197-0186, SUPConference Paper

Bromocriptine induced impotence in Parkinson's diseaseCLEEVES, L; FINDLEY, L.British medical journal (1857). 1987, Vol 295, Num 6594, pp 367-368, issn 0007-1447Article

Failure of ibopamine in the treatment of cirrhotic ascitesMAZZONE, O; CATALANO, D; MANCA, G et al.Current therapeutic research. 1987, Vol 42, Num 4, pp 574-578, issn 0011-393XArticle

Control of hyperprolactinemia with pergolideMATTOX, J. H; BERNSTEIN, J; BUCKMAN, M. T et al.International journal of fertility. 1986, Vol 30, Num 4, pp 39-43, issn 0020-725XArticle